Pubblicazioni

The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements

2021 - ESMO OPEN

Delgado, J.; Pean, E.; Melchiorri, D.; Migali, C.; Josephson, F.; Enzmann, H.; Pignatti, F.

Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: Regulatory aspects

2020 - ESMO OPEN

Moscetti, L.; Hennik, P.; Bolstad, B.; Camarero, J.; Josephson, F.; Melchiorri, D.; Sommerfelt Gronvold, M.; Sjoberg, J.; Botezatu, M.; Mulder, J.; Meulendijks, D.; Trullas Jimeno, A.; Zafiropoulos, N.; Bergh, J.; Enzmann, H.; Pignatti, F.

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST

Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.